David Thompson

4.3k total citations · 3 hit papers
63 papers, 2.6k citations indexed

About

David Thompson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, David Thompson has authored 63 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 18 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Genetics. Recurrent topics in David Thompson's work include Pancreatic function and diabetes (18 papers), Diabetes Management and Research (13 papers) and Diabetes and associated disorders (9 papers). David Thompson is often cited by papers focused on Pancreatic function and diabetes (18 papers), Diabetes Management and Research (13 papers) and Diabetes and associated disorders (9 papers). David Thompson collaborates with scholars based in Canada, United States and United Kingdom. David Thompson's co-authors include Sharon Kozak, Garth L. Warnock, Gordon N. Gill, Ziliang Ao, Peter Sever, R. Jean Shapiro, Neil R Poulter, Howard Berger, Mathew Sermer and Edmond A. Ryan and has published in prestigious journals such as The Lancet, Blood and Nature Biotechnology.

In The Last Decade

David Thompson

59 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes and Pregnancy

2013 295 citations David Thompson, Sharon Kozak et al. profile →
Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes

2021 211 citations Adam Ramzy, David Thompson et al. Cell stem cell profile →
Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device

2021 189 citations David Thompson, Melena D. Bellin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Thompson Canada	25	1.5k	860	611	483	315	63	2.6k
Marina Scavini Italy	31	974 0.7×	1.2k 1.4×	806 1.3×	499 1.0×	131 0.4×	116	3.0k
Emma Hawe United Kingdom	29	630 0.4×	603 0.7×	537 0.9×	515 1.1×	111 0.4×	73	2.6k
Manuel Aguilar‐Diosdado Spain	25	391 0.3×	856 1.0×	371 0.6×	339 0.7×	302 1.0×	152	2.0k
Sally M. Marshall United Kingdom	33	637 0.4×	1.4k 1.7×	536 0.9×	532 1.1×	195 0.6×	93	3.3k
Simon Biron Canada	33	1.9k 1.3×	545 0.6×	113 0.2×	432 0.9×	242 0.8×	71	3.3k
Kun‐san Xiang China	28	738 0.5×	986 1.1×	706 1.2×	1.5k 3.0×	77 0.2×	118	3.2k
Leszek Czupryniak Poland	23	577 0.4×	732 0.9×	186 0.3×	222 0.5×	141 0.4×	121	1.9k
Wenquan Niu China	32	488 0.3×	605 0.7×	343 0.6×	743 1.5×	92 0.3×	191	3.1k
Trent Tracy United States	34	1.2k 0.8×	649 0.8×	136 0.2×	302 0.6×	217 0.7×	53	3.2k
W Grzeszczak Poland	31	429 0.3×	969 1.1×	382 0.6×	587 1.2×	80 0.3×	298	3.2k

Countries citing papers authored by David Thompson

Since Specialization

Citations

This map shows the geographic impact of David Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Thompson more than expected).

Fields of papers citing papers by David Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Thompson. The network helps show where David Thompson may publish in the future.

Co-authorship network of co-authors of David Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of David Thompson. A scholar is included among the top collaborators of David Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Thompson. David Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bond, Toby, et al.. (2025). In‐Situ Heating X‐Ray Diffraction of LiNi _0.6 Mn _0.3 Co _0.1 O ₂ and LiNi _0.7 Mn _0.3 O ₂ Made Using the All‐Dry Synthesis Process. Small Methods. 10(2). e2500632–e2500632.

Keymeulen, Bart, Daniel Jacobs‐Tulleneers‐Thevissen, David Thompson, et al.. (2023). Encapsulated stem cell–derived β cells exert glucose control in patients with type 1 diabetes. Nature Biotechnology. 42(10). 1507–1514. 53 indexed citations

Ganesananthan, Sashiananthan, Christopher Rajkumar, Michael Foley, et al.. (2022). Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial. European Heart Journal. 43(33). 3132–3145. 13 indexed citations

Ramzy, Adam, David Thompson, Kirsten A. Ward‐Hartstonge, et al.. (2021). Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell stem cell. 28(12). 2047–2061.e5. 211 indexed citations breakdown →

Howard, James P., Frances A. Wood, Judith A. Finegold, et al.. (2021). Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment. Journal of the American College of Cardiology. 78(12). 1210–1222. 116 indexed citations

Poulter, Neil R, Christos Savopoulos, Aisha Anjum, et al.. (2018). Randomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood Pressure. Hypertension. 72(4). 870–873. 53 indexed citations

Gupta, Ajay, David Thompson, Andrew Whitehouse, et al.. (2017). Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. The Lancet. 389(10088). 2473–2481. 218 indexed citations

Lively, Kathryn J., David Thompson, Amanda Sheffield Morris, et al.. (2017). Mothers’ self-reported grocery shopping behaviours with their 2- to 7-year-old children: relationship between feeding practices and mothers’ willingness to purchase child-requested nutrient-poor, marketed foods, and fruits and vegetables. Public Health Nutrition. 20(18). 3343–3348. 6 indexed citations

Thompson, David, et al.. (2017). Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention. JMIR mhealth and uhealth. 5(6). e76–e76. 15 indexed citations

10.

Mutalib, Mohamed, et al.. (2017). Management of pneumatosis intestinalis in children over the age of 6 months: a conservative approach. Archives of Disease in Childhood. 103(4). 352–355. 13 indexed citations

11.

Mancini, G.B. John, Alice Cheng, Kim A. Connelly, et al.. (2016). Diabetes for Cardiologists: Practical Issues in Diagnosis and Management. Canadian Journal of Cardiology. 33(3). 366–377. 20 indexed citations

12.

Levy‐Cooperman, Naama, et al.. (2016). Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users. Journal of Opioid Management. 12(3). 165–180. 1 indexed citations

13.

Harris, Claire, et al.. (2016). Islet cell transplantation improves nerve conduction velocity in type 1 diabetes compared with intensive medical therapy over six years. Diabetes Research and Clinical Practice. 122. 101–105. 13 indexed citations

14.

Meneilly, Graydon S., et al.. (2014). The effect of hyperinsulinemia and hyperglycemia on endothelial function in pregnant patients with type-2 diabetes. Diabetes Research and Clinical Practice. 103(3). e11–e13. 2 indexed citations

15.

Thompson, David, et al.. (2009). Same-Patient Reproducibility of State Entropy: A Comparison of Simultaneous Bilateral Measurements During General Anesthesia. Anesthesia & Analgesia. 108(6). 1830–1835. 7 indexed citations

16.

Thompson, David, I S Begg, Claire Harris, et al.. (2008). Reduced Progression of Diabetic Retinopathy After Islet Cell Transplantation Compared With Intensive Medical Therapy. Transplantation. 85(10). 1400–1405. 48 indexed citations

17.

Thompson, David, et al.. (2007). Cost-Effectiveness of Switching to Exemestane after 2 to 3 Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer. Value in Health. 10(5). 367–376. 25 indexed citations

18.

Shord, Stacy S., David Thompson, Greg A. Krempl, & Marie H. Hanigan. (2006). Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anti-Cancer Drugs. 17(2). 207–215. 59 indexed citations

19.

Greenwood, Darren C., Janet Cade, Jennifer Moreton, et al.. (2005). HFE Genotype Modifies the Influence of Heme Iron Intake on Iron Status. Epidemiology. 16(6). 802–805. 17 indexed citations

20.

Kozak, Sharon, et al.. (2004). Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial. The American Journal of Medicine. 116(4). 230–235. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact